ArticleNeuro-oncology advances
Pattern of care and treatment outcome of high-grade glioma patients at 4 Ethiopian teaching hospitals: a prospective cohort study.
Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- High-grade gliomas where resources define survival: a systematic review and meta-analysis of outcomes, surgical access, and molecular diagnostic gaps in low- and middle-income countries.Frontiers in oncology · 2026Pooled it
- State of high-grade glioma care in Africa: insights from a scoping review of the available published literature.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High-grade gliomas are the most prevalent type of malignant brain tumor in adults and the second leading cause of cancer-related death. This study assesses epidemiology, pattern of care, and treatment outcome of high-grade glioma in Ethiopia. Methods: A Prospective cohort study. Data collected were analyzed using SPSS. Frequency distribution was used to describe the characteristics of the study participants. Chi-squared tests and survival analysis were used to assess the treatment outcomes. Variables with Results: There was a total of 40 patients. The median age at diagnosis was 47 years. Headache was the commonest presenting symptom (97.5%), followed by seizure (52.5%) and weakness (50%). The pre-operative tumor volume ranged between 3.9 and 168 cm Conclusion: In our study, the mean survival time was 20.77 months. Higher KPS, pre-operative Glasgow Coma Scale (GCS) of 15, and patients receiving post-op adjuvant therapy had a significant favorable association with survival in our study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.